TRPV1 variants impair intracellular Ca(2+) signaling and may confer susceptibility to malignant hyperthermia

PURPOSE: Malignant hyperthermia (MH) is a pharmacogenetic disorder arising from uncontrolled muscle calcium release due to an abnormality in the sarcoplasmic reticulum (SR) calcium-release mechanism triggered by halogenated inhalational anesthetics. However, the molecular mechanisms involved are sti...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanden Abeele, Fabien, Lotteau, Sabine, Ducreux, Sylvie, Dubois, Charlotte, Monnier, Nicole, Hanna, Amy, Gkika, Dimitra, Romestaing, Caroline, Noyer, Lucile, Flourakis, Matthieu, Tessier, Nolwenn, Al-Mawla, Ribal, Chouabe, Christophe, Lefai, Etienne, Lunardi, Joël, Hamilton, Susan, Fauré, Julien, Van Coppenolle, Fabien, Prevarskaya, Natalia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752298/
https://www.ncbi.nlm.nih.gov/pubmed/29930394
http://dx.doi.org/10.1038/s41436-018-0066-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6752298/
https://www.ncbi.nlm.nih.gov/pubmed/29930394
http://dx.doi.org/10.1038/s41436-018-0066-9

Ejemplares similares